Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Ny behandling af kronisk hepatitis B
Engelsk titel: New treatment of chronic hepatitis B Läs online Författare: Sloth Andersen E ; Weis NM Språk: Dan Antal referenser: 10 Dokumenttyp: Artikel UI-nummer: 09011643

Tidskrift

Ugeskrift for Laeger 2008;170(48)3937-9 ISSN 0041-5782 E-ISSN 1603-6824 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

Worldwide, 350 million people are infected with chronic hepatitis B. Over the last few years, it has been possible to treat chronic hepatitis B. Treatment very often consists of nucleos(t)ide analogs and in a few cases of pegylated a -interferon. In 2007, a new nucleoside analog, Telbivudine, was approved to treat chronic hepatitis B. In phase II and ongoing phase III studies, Telbivudine has proven more effective than the nucleoside analog, Lamivudine, which was very often used up until recently.